Medicover AB (publ)
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a MCVEF research report →
Companywww.medicover.com
Medicover AB (publ) provides healthcare and diagnostic services in Germany, Sweden, Poland, Turkey, Belarus, Bulgaria, Georgia, Hungary, Serbia, Moldova, Ukraine, and India. It operates through two segment, Healthcare Services and Diagnostic Services. The company's diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
- CEO
- John Paul Stubbington
- IPO
- 2019
- Employees
- 47,000
- HQ
- Stockholm, SE
Price Chart
Valuation
- Market Cap
- $4.11B
- P/E
- 37.73
- P/S
- 1.24
- P/B
- 5.50
- EV/EBITDA
- 11.24
- Div Yield
- 1.00%
Profitability
- Gross Margin
- 23.32%
- Op Margin
- 6.87%
- Net Margin
- 3.28%
- ROE
- 15.50%
- ROIC
- 5.99%
Growth & Income
- Revenue
- $2.38B · 13.69%
- Net Income
- $77.50M · 364.07%
- EPS
- $0.51 · 363.64%
- Op Income
- $155.70M
- FCF YoY
- 32.95%
Performance & Tape
- 52W High
- $27.25
- 52W Low
- $18.00
- 50D MA
- $27.25
- 200D MA
- $26.73
- Beta
- 1.50
- Avg Volume
- 525.66
Get TickerSpark's AI analysis on MCVEF
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our MCVEF Coverage
We haven't published any research on MCVEF yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate MCVEF Report →